Dr. Ramchand
Dr. Satish Chandran
Dr. Satish Chandran
Dr. Ramchand has a rich industrial and academic background in the field of drug discovery, nanotechnology and nutraceuticals. He has held key leadership roles in industries such as India Director & World Wide Executive Member at Kemin Industries South Asia Pvt Ltd. India and Vice President & Head of New Drug Discovery (biological)
Dr. Ramchand has a rich industrial and academic background in the field of drug discovery, nanotechnology and nutraceuticals. He has held key leadership roles in industries such as India Director & World Wide Executive Member at Kemin Industries South Asia Pvt Ltd. India and Vice President & Head of New Drug Discovery (biological) Research Programme at Sun Pharma Advances Research Centre (SPARC) India. He has also held the position of Joint Co-ordinator and Head, Laboratory Research Program at Biomedical Sciences, University of Sheffield and Northern General Hospital Sheffield, UK, a prestigious University Position. Prior to this he was the Sr. Scientist and Project Head at the Institute of Biological Psychiatry at University of Wales, Bangor, UK.
He has also worked as Senior Research Officer at the Biochemistry Department, University of North Wales, Bangor, UK. He has over 25 years of rich experience in the areas of teaching, basic research, Drug Discovery Programme and Disease Mechanism, guiding M.Sc./Ph.D students and setting up Research facility. Dr. Ramchand has closely worked on several molecules and many of these are at different stages of clinical trials. Dr. Ramchand has published over 70 peer-reviewed papers in international journals, edited 5 books, has over 40 patents either issued or in process.
Dr. Satish Chandran
Dr. Satish Chandran
Dr. Satish Chandran
Dr. Satish Chandran is the CEO & Board Member Prodigy Biotech, Inc., Pennsylvania
Distinguished biotech veteran with nearly 25 years of significant leadership experience in biotechnology.
He received his Ph.D. from Memorial University in Newfoundland, Canada, and completed a post-doctoral fellowship at Fox Chase Cancer Center in Philade
Dr. Satish Chandran is the CEO & Board Member Prodigy Biotech, Inc., Pennsylvania
Distinguished biotech veteran with nearly 25 years of significant leadership experience in biotechnology.
He received his Ph.D. from Memorial University in Newfoundland, Canada, and completed a post-doctoral fellowship at Fox Chase Cancer Center in Philadelphia.
He Is a strategic consultant and a member of the Board of Directors for several emerging and established biotechnology companies.
He Has been CTO, President and COO of Marizyme; President and CEO of Somahlution Inc.; COO and CSO at Nucleonics, Horsham PA (the first RNAibased Biotechnology Company he co-founded).
Headed up the DNA Vaccine Division of Wyeth-LederleVaccines where his group advanced multiple DNA vaccine-based product candidates in infectious diseases and cancer into clinical studies.
Why Collaborate with Us ?
We understand the complexities and challenges of bringing new products to market.By partnering with us, you gain access to:
Unparalleled expertise and insights
Our team brings a wealth of experience and knowledge to every project, ensuring high-quality outcomes and innovative solutions.
Comprehensive Support
From initial discovery and development to advanced clinical evaluations,we offer end-to-end services tailored to meet your specific needs.
Regulatory Compliance
We are well-versed in regulatory requirements and can assist with patent writing,filing and submissions to regulatory bodies such as the Recombinant DNA Advisory Committee (RCGM) and the U.S Food and Drug Administration (FDA).
Accelerated Timelines:
Our efficient processes and streamlined workflows enable us to expedite development timelines without compromising on quality or safety.
Get in Touch
Ready to take your product development to the next level? We invite you to explore our website to learn more about our services and capabilities.For inquiries or to discuss potential collaboration opportunities, please contact us.We look forward to partnering with you to bring your innovative ideas into life.